A Pragmatic Randomised Clinical Trial of Nicotine Vaporisers added to Smoking Cessation Treatment for Priority Populations Living with Comorbidities

一项针对患有合并症的优先人群在戒烟治疗中添加尼古丁汽化器的实用随机临床试验

• 批准号: nhmrc : 1124264
• 负责人: A/Pr Coral Gartner
• 金额: $ 102.37万
• 依托单位: The University of Queensland
• 依托单位国家: 澳大利亚
• 项目类别: Project Grants
• 财政年份: 2017
• 资助国家: 澳大利亚
• 起止时间: 2017-01-01 至 2021-12-31
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/pragmatic-randomised-clinical-living-comorbidities/947308
• 关键词: Pragmatic; Randomised; Clinical; Trial; Nicotine

Smoking is a leading cause of early death for people with certain health conditions because they are more likely to smoke and are also at greater risk of tobacco-related disease. This clinical trial will test whether encouraging people living with Hepatitis C Virus, people on opiate substitution therapy and people living with HIV who smoke to use nicotine vaporisers long-term, in addition to current smoking cessation treatments, will help them to stay abstinent from smoking.

吸烟是具有某些健康状况的人过早死亡的主要原因，因为他们更有可能吸烟，也更有可能患上与烟草有关的疾病。这项临床试验将测试，除了目前的戒烟治疗外，鼓励丙型肝炎病毒携带者、接受阿片类药物替代疗法的人和艾滋病毒携带者长期使用尼古丁雾化器是否有助于他们戒烟。